GW Pharmaceuticals Plc's Director of Research Stephen Wright

GW Pharmaceuticals Plc's Director of Research Stephen Wright

Simon Jarrett via Bloomberg

GW Pharmaceuticals Plc's director of research Stephen Wright, said that GW Pharma is planning a follow-up mid-stage study later this year in the hopes that it works better to attack diabetes on multiple fronts compared with existing treatments.